EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,824,000 | -13.4% | 213,822 | -5.5% | 0.04% | -11.9% |
| Q2 2018 | $17,124,000 | -35.1% | 226,333 | -54.8% | 0.04% | -36.4% |
| Q1 2018 | $26,394,000 | -17.9% | 500,922 | -16.7% | 0.07% | -13.2% |
| Q4 2017 | $32,132,000 | -10.4% | 601,505 | 0.0% | 0.08% | -5.0% |
| Q3 2017 | $35,874,000 | -30.2% | 601,505 | -7.7% | 0.08% | -35.0% |
| Q2 2017 | $51,397,000 | -6.3% | 651,505 | -1.4% | 0.12% | -8.9% |
| Q1 2017 | $54,824,000 | +8.9% | 661,005 | +4.1% | 0.14% | +5.5% |
| Q4 2016 | $50,365,000 | +26.6% | 634,805 | +11.7% | 0.13% | +28.0% |
| Q3 2016 | $39,774,000 | – | 568,205 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |